In the design stage, we will use both traditional methods of molecular analogy with other known active compounds, and cheminformatic methods that include neural network and modeling (docking studies). All aimed at finding new drugs to be studied both in vitro to establish a possible mechanism of action, in vivo in animal models to establish their possible therapeutic application in AD and PD.